Analyst Upgrades for 11/17/2009... Alkermes (NASDAQ:ALKS) upgraded to Outperform at Leerink Swann... Barclays (NYSE:BCS) upgraded to buy from Neutral at Nomura... Carmike Cinemas (NASDAQ:CKEC) upgraded to Buy, $8.50-11 target, Merriman Curhan Ford... Devon Energy (NYSE:DVN) upgraded to Outperform, $80-84 target, at Wells Fargo... Dover (NYSE:DOV) reiterated Buy, target raised to $48, at Deutsche Bank... Exxon Mobil (NYSE:XOM) upgraded to Overweight from Equal Weight, $92 target, at Barclays... Hess Corp (NYSE:HES) upgraded to Buy from Neutral at UBS... Illinois Tool Works (NYSE:ITW) upgraded to Buy from Neutral at UBS... Kellogg (NYSE:K) reiterated Buy, $59 target, at Deutsche Bank... Lear Corp. (NYSE:LEA) initiated as Overweight at JPMorgan... Medicis Pharmaceutical (NYSE:MRX) upgraded to Neutral, $20 target, at Piper Jaffray... Mistras (NYSE:MG) initiated as Overweight at JP Morgan, an Outperform at Credit Suisse and a Buy at BofA/Merrill... Netflix Inc. (NASDAQ:NFLX) initiated as Buy at Collins Stewart... Omeros (NASDAQ:OMER) initiated as Buy at Deutsche Bank... Palm (NASDAQ:PALM) upgraded to Buy from Hold, $16 target, at Kaufman Bros... Sasol Ltd (NYSE:SSL) upgraded to Buy from Neutral at UBS...

Contact Chip Brian

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at www.TradeTheTrend.com/signup.html